ligD Antibody

Shipped with Ice Packs
In Stock

Description

Functional Roles of IgD Antibody

IgD exhibits dual functionality:

RoleMechanismClinical Relevance
B-Cell ActivationCo-expressed with IgM on naïve B cells; regulates BCR signaling thresholds .Potential target in autoimmune disorders .
Mucosal ImmunitySecreted in respiratory mucosa; binds pathogens (Moraxella catarrhalis, H. influenzae) .Compensatory increase in IgA-deficient patients .
Basophil InteractionBinds basophils via unknown receptor, inducing IL-4/IL-13 release and antimicrobial peptide production .Enhances innate and adaptive immune responses against respiratory infections .

Key Studies and Data

  1. Class-Switch Recombination (CSR)

    • IgD CSR from IgM requires activation-induced cytidine deaminase (AID) and CD40L/BAFF/APRIL signaling .

    • Patients with AID deficiency show absent IgD-switched plasmablasts .

  2. Pathogen Neutralization

    • Mucosal IgD binds virulence factors of respiratory pathogens, reducing colonization .

    • In vitro studies demonstrate IgD-mediated phagocytosis enhancement by 40–60% in basophil co-cultures .

  3. Therapeutic Potential

    • IgD levels inversely correlate with disease severity in common variable immunodeficiency (CVID) .

    • Preclinical models suggest targeting IgD-basophil axis could modulate allergic inflammation .

Challenges and Future Directions

  • Stability Issues: Serum IgD’s short half-life (2.8 days) limits therapeutic applications .

  • Receptor Identification: The IgD receptor on basophils remains uncharacterized, hindering mechanistic studies .

  • Clinical Trials: No IgD-targeted therapies are currently in development, though its role in mucosal immunity warrants further exploration .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ligD antibody; MSMEG_5570 antibody; MSMEI_5419Multifunctional non-homologous end joining protein LigD antibody; NHEJ DNA polymerase) [Includes: DNA repair polymerase antibody; Pol antibody; Polymerase/primase); 3'-phosphoesterase antibody; 3'-ribonuclease/3'-phosphatase antibody; PE); DNA ligase antibody; Lig antibody; EC 6.5.1.1 antibody; Polydeoxyribonucleotide synthase [ATP])] antibody
Target Names
ligD
Uniprot No.

Target Background

Function
LigD forms a non-homologous end joining (NHEJ) repair enzyme complex with Ku. This complex repairs blunt-end and 5'-overhang DNA double-strand breaks (DSBs) with approximately 50% fidelity, as well as DSBs with non-complementary 3' ends. It plays a partial role in NHEJ during 3'-overhang repair. NHEJ repairs DSBs with blunt ends and 5' overhangs with a high level of nucleotide insertion/deletion, without requiring microhomology. LigD acts as a DNA ligase on singly nicked dsDNA, as a DNA-directed DNA polymerase on 5' overhangs, and adds non-templated nucleotides to 3' overhangs (terminal transferase). It fills in gaps in dsDNA, demonstrating a preference for a 5'-phosphate in the gap. Site-directed mutations resulting in ligase loss alter the bias from insertion to deletion mutations, indicating that another ligase (LigC1 and/or LigC2) can compensate. The polymerase domain's preference for rNTPs over dNTPs may be advantageous in dormant cells, where the dNTP pool may be limiting. The ligase activity is required for the replication of viruses with short cos ends (4 bases) such as Mycobacterium phage Omega and Corndog, but not D29, which has a 9 base cos end. LigD stimulates dsDNA end joining by LigD. When expressed with endogenous or Mycobacterium phage Omega Ku, LigD can reconstitute NHEJ in S. cerevisiae.
Database Links
Protein Families
LigD polymerase family; LigD 3'-phosphoesterase family; ATP-dependent DNA ligase family

Q&A

What is ligD and what role does it play in different biological systems?

ligD refers to different proteins depending on the biological context:

In mycobacteria such as Mycobacterium smegmatis, ligD functions as a multifunctional non-homologous end joining (NHEJ) protein involved in DNA repair . This protein is crucial for repairing double-strand breaks without requiring extensive sequence homology.

In Sphingomonas paucimobilis, ligD is part of the ligDFG enzyme system responsible for lignin degradation, specifically cleaving β-aryl ether bonds . The lignin β-aryl ether (β-O-4) linkage is the most abundant interunit connection in lignin, and ligD catalyzes the initial dehydrogenation step in a three-enzyme process .

Understanding which ligD variant your research focuses on is essential for selecting appropriate antibodies and experimental approaches.

What are the key considerations when selecting a ligD antibody for research applications?

When selecting a ligD antibody, researchers should consider:

  • Target specificity: Ensure the antibody recognizes your specific ligD protein (bacterial DNA repair vs. lignin-degrading variants)

  • Host species: Consider the host in which the antibody was raised (rabbit polyclonal is common for ligD antibodies)

  • Application compatibility: Verify validation for your intended applications (WB, ELISA, IF, IP)

  • Epitope location: Antibodies targeting different regions may yield different results

  • Clonality: Polyclonal antibodies offer broader epitope recognition while monoclonals provide higher specificity

Antibody TypeAdvantagesLimitationsBest Applications
Polyclonal anti-ligDMultiple epitope recognition, robust signalPotential for cross-reactivityInitial detection, WB, IP
Monoclonal anti-ligDHigh specificity, lot-to-lot consistencyLimited epitope recognitionSpecific localization, quantification
Tagged-protein antibodiesHigh specificity when using tagged ligDRequires genetic modificationSystems with engineered ligD

For optimal results with ligD antibodies like CSB-PA620474XA01MVX, proper storage at -20°C or -80°C with minimal freeze-thaw cycles is essential .

How do bacterial and plant-expressed ligD antibody applications differ in research contexts?

The applications of ligD antibodies differ significantly between bacterial and plant research contexts:

Bacterial ligD antibody applications:

  • Detection of native ligD in mycobacterial species

  • Studying DNA repair mechanisms in bacteria

  • Investigating bacterial stress responses and survival mechanisms

  • Analyzing NHEJ pathways in prokaryotes

Plant-expressed bacterial ligD antibody applications:

  • Confirming successful transformation with bacterial ligD genes

  • Monitoring expression levels across different transgenic lines

  • Tracking protein localization in plant tissues (typically secretory pathway-targeted)

  • Correlating protein expression with lignin modification phenotypes

In transgenic plant systems, researchers must consider signal peptide efficiency when targeting bacterial ligD to the secretory pathway. Search results show that both amy (barley α-amylase) and ppi (potato proteinase inhibitor II) signal peptides have been successfully used to target ligD to the apoplast in Arabidopsis .

What are the recommended protocols for detecting ligD using Western blotting?

For optimal Western blot detection of ligD, follow these methodological guidelines:

Sample preparation:

  • For bacterial samples: Lyse cells in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, with protease inhibitors

  • For plant samples expressing bacterial ligD: Homogenize in buffer containing 50 mM HEPES (pH 7.5), 10% glycerol, 1 mM EDTA, with protease inhibitors

Gel electrophoresis:

  • Use 7.5-10% SDS-PAGE for optimal resolution

  • Load 30 μg of whole cell extract per lane

Transfer conditions:

  • Transfer to PVDF membrane (preferred over nitrocellulose for better protein retention)

  • Use semi-dry transfer at 15V for 60 minutes or wet transfer at 100V for 90 minutes

Blocking and antibody incubation:

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with primary anti-ligD antibody at 1:500 dilution (adjust based on specific antibody)

  • Incubate overnight at 4°C for optimal binding

  • Wash 4-5 times with TBST

  • Incubate with appropriate HRP-conjugated secondary antibody at 1:5000 dilution

Detection:

  • Visualize using enhanced chemiluminescence (ECL) substrates

  • For plant-expressed bacterial ligD, expect a band at approximately 32 kDa

Controls:

  • Positive control: Known ligD-expressing sample

  • Negative control: Non-transformed or knockout sample

  • Loading control: Housekeeping protein like GAPDH or β-actin

As demonstrated in research with transgenic Arabidopsis, anti-ligD antibodies can successfully detect the protein in plant extracts with minimal cross-reactivity to plant proteins .

How can researchers optimize immunoprecipitation protocols with ligD antibodies?

Optimizing immunoprecipitation (IP) protocols for ligD requires careful consideration of several factors:

Pre-clearing and antibody binding:

  • Pre-clear lysates with appropriate beads for 1 hour at 4°C

  • Use 2-5 μg of ligD antibody per 500 μg total protein

  • Incubate overnight at 4°C with gentle rotation to maximize antigen capture

Bead selection and handling:

  • For rabbit polyclonal ligD antibodies: Use Protein A beads

  • Consider magnetic beads for gentler handling and reduced background

  • Add beads for 2-4 hours after antibody incubation

Washing optimization:

  • Perform at least 4-5 washes with buffers of increasing stringency

  • Initial washes with IP buffer containing 0.1% detergent

  • Follow with higher salt washes (150-500 mM NaCl)

  • Perform final wash in detergent-free buffer

Elution strategies:

  • For Western blot analysis: Elute directly in SDS sample buffer (95°C, 5 minutes)

  • For mass spectrometry analysis: Use gentle elution with 0.1M glycine buffer (pH 2.5)

  • For activity assays: Consider competitive elution with excess antigen peptide

Critical controls:

  • Input sample (5-10% of starting material)

  • IgG control (same species as ligD antibody)

  • IP without antibody (beads only)

For studying interactions between ligD and other proteins, consider a modified protocol used in DNA repair studies where cross-linking prior to IP may preserve transient interactions .

What validation approaches should be used when working with new ligD antibodies?

Comprehensive validation is essential when working with new ligD antibodies to ensure specificity and reliability:

Essential validation experiments:

  • Western blot characterization:

    • Verify single band at expected molecular weight

    • Compare band intensity across samples with known expression levels

    • Include positive and negative controls

  • Genetic validation:

    • Test antibody against ligD knockout or knockdown samples

    • Examine overexpression systems with tagged ligD constructs

    • Use CRISPR-edited cell lines when available

  • Peptide competition:

    • Pre-incubate antibody with immunizing peptide

    • Observe elimination of specific signal

    • Use titrated peptide concentrations

  • Cross-species reactivity:

    • Test against ligD from different bacterial species

    • Verify specificity against host proteins in transgenic systems

    • Document species limitations

For ligD antibodies like CSB-PA620474XA01MVX, validation should confirm reactivity with Mycobacterium smegmatis (strain ATCC 700084) as specified in manufacturer documentation .

Advanced validation approaches:

  • Mass spectrometry confirmation of immunoprecipitated proteins

  • Orthogonal detection methods (multiple antibodies targeting different epitopes)

  • Functional correlation (antibody signal versus enzymatic activity)

How can ligD antibodies be utilized to investigate DNA repair mechanisms in mycobacteria?

ligD antibodies offer valuable tools for investigating mycobacterial DNA repair mechanisms through several sophisticated approaches:

Spatiotemporal analysis of repair complex formation:

  • Use immunofluorescence with anti-ligD antibodies to track protein recruitment to damage sites

  • Combine with other DNA repair markers to establish repair pathway hierarchy

  • Perform time-course experiments after DNA damage induction

Protein-protein interaction studies:

  • Employ co-immunoprecipitation with ligD antibodies to identify repair complex components

  • Use proximity ligation assays (PLA) to visualize direct interactions in situ

  • Combine with mass spectrometry for comprehensive interactome analysis

Functional inhibition studies:

  • Apply neutralizing ligD antibodies in cell-free repair assays

  • Microinject antibodies to study cellular consequences of ligD inhibition

  • Create domain-specific antibodies to distinguish repair functions

Expression regulation analysis:

  • Monitor ligD levels under various stress conditions using quantitative immunoblotting

  • Correlate protein expression with transcriptional regulation

  • Analyze post-translational modifications affecting ligD function

Chromatin immunoprecipitation approaches:

  • Use ligD antibodies for ChIP to identify DNA binding sites

  • Perform sequential ChIP to analyze repair factor recruitment order

  • Combine with high-throughput sequencing for genome-wide analysis

These approaches are particularly important for understanding how mycobacteria maintain genomic integrity under stress conditions, with implications for tuberculosis research and antibiotic resistance mechanisms.

What methodological approaches can effectively study ligD's role in lignin modification using antibodies?

Based on search result , researchers investigating ligD's role in lignin modification can employ several antibody-based methodological approaches:

Expression verification in transgenic systems:

  • Use Western blotting with anti-ligD antibodies to confirm transformation success

  • Quantify expression levels across independent transgenic lines

  • Monitor expression stability across generations

Activity correlation studies:

  • Correlate ligD protein levels with lignin modification metrics

  • Combine antibody detection with analytical chemistry (NMR, UHPLC-MS)

  • Track changes in oxidized guaiacyl (Gox) and syringyl (Sox) lignin units

Subcellular localization analysis:

  • Immunogold electron microscopy for precise localization

  • Fractionation studies followed by immunoblotting

  • Verify secretory pathway targeting using compartment markers

Tissue-specific expression patterns:

  • Immunohistochemistry to map ligD expression across plant tissues

  • Correlate with lignin deposition patterns

  • Analyze temporal expression during development

In transgenic Arabidopsis research, antibodies have successfully tracked ligD expression from the tri-cistronic amyDFG and ppiDFG constructs, revealing consistent protein expression across biological replicates in some lines (amyDFG10) while showing variable expression in others (ppiDFG1, amyDFG1) .

Technical implementation:

  • Use polyclonal antibodies raised against the specific bacterial ligD variant

  • Include appropriate controls (non-transformed plants)

  • Consider extractable protein yield differences between tissues

How can antibody-based techniques elucidate the structure-function relationship of ligD proteins?

Antibody-based techniques offer powerful approaches to investigating structure-function relationships in ligD proteins:

Domain-specific antibody applications:

  • Generate antibodies targeting specific functional domains

  • Track domain accessibility under different conditions

  • Identify critical regions for protein-protein interactions

Conformational state analysis:

  • Develop conformation-specific antibodies recognizing active/inactive states

  • Monitor structural changes upon substrate binding

  • Assess allosteric regulation mechanisms

Mapping functional epitopes:

  • Use epitope mapping with overlapping peptides to identify key regions

  • Correlate antibody binding with functional inhibition

  • Develop function-blocking antibodies targeting catalytic sites

Post-translational modification analysis:

  • Generate modification-specific antibodies (phospho-, acetyl-, etc.)

  • Track modification status under different conditions

  • Correlate modifications with enzymatic activity

Structure-guided antibody engineering:

  • Use structural information to design antibodies targeting specific interfaces

  • Develop antibodies that stabilize or disrupt protein complexes

  • Create biosensors based on conformation-specific antibodies

These approaches are particularly valuable for distinguishing between ligD's different activities in DNA repair contexts (where it exhibits polymerase, ligase, and nuclease functions) or in lignin degradation (where it functions as a dehydrogenase).

What strategies effectively address non-specific binding when using ligD antibodies?

Non-specific binding is a common challenge with ligD antibodies that can be addressed through several systematic approaches:

Optimizing blocking conditions:

  • Test different blocking agents (5% milk, 3-5% BSA, commercial blockers)

  • Extend blocking time to 2 hours or overnight at 4°C

  • Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

Antibody dilution optimization:

  • Perform titration experiments to determine minimal effective concentration

  • Prepare antibody dilutions in blocking buffer

  • Consider adding 0.1% carrier protein to stabilize diluted antibody

Increasing wash stringency:

  • Increase number of washes (minimum 5-6 washes)

  • Extend wash duration (10-15 minutes per wash)

  • Add higher salt concentration (up to 500 mM NaCl) to wash buffers

Pre-absorption techniques:

  • Pre-incubate antibody with proteins from negative control samples

  • Use acetone powder from non-expressing tissues

  • Consider affinity purification against the immunizing antigen

Sample-specific modifications:

  • For bacterial samples: Additional purification steps to remove similar ligases

  • For plant samples expressing bacterial ligD: Pre-clear with wild-type plant extract

Technical adjustments:

  • For Western blots: Use freshly prepared buffers and avoid membrane overexposure

  • For immunofluorescence: Include autofluorescence quenching steps

  • For immunoprecipitation: Use pre-clearing steps with beads alone

When working with mycobacterial ligD antibodies, cross-reactivity with host DNA ligases can occur due to functional conservation. Using antibodies raised against unique regions helps minimize this issue.

How can researchers overcome low signal issues when detecting ligD in experimental samples?

Low signal detection when working with ligD antibodies requires systematic troubleshooting:

Sample preparation optimization:

  • Enrich for relevant subcellular fractions

  • Use protease inhibitors to prevent degradation

  • Optimize extraction buffers for the specific sample type

  • Consider concentration methods (TCA precipitation, ultrafiltration)

Antibody-related enhancements:

  • Try alternative antibody clones targeting different epitopes

  • Increase antibody concentration (within reasonable limits)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use fresh antibody aliquots to avoid degradation

Signal amplification methods:

  • For Western blots: Use high-sensitivity ECL substrates

  • For immunofluorescence: Implement tyramide signal amplification (TSA)

  • Consider biotin-streptavidin amplification systems

  • Use polymer-based detection methods

Protocol modifications:

  • Reduce washing stringency slightly (lower salt, shorter washes)

  • Optimize antigen retrieval for fixed samples

  • Extend development time for chromogenic detection

  • Use PVDF membranes instead of nitrocellulose for better protein retention

Sample-specific considerations:

  • For mycobacterial ligD: Enhanced cell wall disruption may be necessary

  • For plant-expressed ligD: Remove interfering cell wall components

  • For recombinant systems: Verify expression timing and conditions

In plant systems expressing bacterial ligD, comparing different targeting strategies (amy vs. ppi signal peptides) can help identify constructs with stronger expression and better detection .

What approaches can distinguish between different ligases when using antibodies in complex systems?

Distinguishing between different ligases presents a significant challenge that requires specialized approaches:

Epitope selection strategies:

  • Target unique sequences not conserved across ligase family members

  • Design peptide antigens from divergent regions

  • Avoid catalytic domains with high conservation

Validation with genetic models:

  • Test antibodies against knockout lines for each ligase

  • Use overexpression systems with tagged versions of each ligase

  • Perform systematic cross-reactivity testing

Advanced immunological approaches:

  • Develop sandwich ELISA systems with capture/detection antibodies targeting different epitopes

  • Use competition assays with purified proteins to determine specificity

  • Implement sequential immunodepletion to remove cross-reactive species

Analytical validation:

  • Combine antibody detection with mass spectrometry for protein identification

  • Correlate antibody signal with enzymatic activity specific to each ligase

  • Use size differences to distinguish between ligase family members

Technical implementation:

  • For Western blotting: Use gradient gels to separate similar-sized ligases

  • For immunofluorescence: Perform sequential staining with different antibodies

  • For immunoprecipitation: Confirm pulled-down proteins by mass spectrometry

When working with multiple DNA ligases, research has demonstrated that immunodepletion with specific antibodies can effectively distinguish the roles of ligases I, III, and IV in different DNA repair pathways .

What are the optimal immunofluorescence protocols for detecting ligD in different biological systems?

Optimizing immunofluorescence for ligD detection requires tailored protocols for different biological systems:

For bacterial cells expressing ligD:

  • Fixation: 4% paraformaldehyde, 15 minutes at room temperature

  • Permeabilization: 0.1% Triton X-100 with lysozyme treatment (10 mg/ml, 30 minutes)

  • Blocking: 5% BSA in PBS, 1 hour at room temperature

  • Primary antibody: Anti-ligD at 1:200 dilution, overnight at 4°C

  • Secondary antibody: Species-specific fluorophore-conjugated, 1:500, 1 hour at room temperature

  • Counterstain: DAPI (1 μg/ml) for nucleoid visualization

  • Mounting: Anti-fade mounting medium

For plant tissues expressing bacterial ligD:

  • Fixation: 4% paraformaldehyde with 0.1% glutaraldehyde, 1 hour

  • Cell wall digestion: Enzymatic treatment with pectolyase/cellulase (optional)

  • Permeabilization: 0.2% Triton X-100, 30 minutes

  • Blocking: 3% BSA with 10% normal serum, 2 hours

  • Primary antibody: Anti-ligD at 1:100-1:200, 48 hours at 4°C

  • Secondary antibody: Highly cross-adsorbed variant, 1:300, overnight at 4°C

  • Autofluorescence quenching: 0.1% Sudan Black in 70% ethanol

  • Z-stack imaging: For comprehensive tissue analysis

For mammalian cells expressing recombinant ligD:

  • Fixation: 4% paraformaldehyde, 10 minutes

  • Permeabilization: 0.1% Triton X-100, 5 minutes

  • Blocking: 5% normal serum, 1 hour

  • Primary antibody: Anti-ligD at 1:200-1:400, overnight at 4°C

  • Secondary antibody: Species-specific conjugate, 1:500, 1 hour

  • Nuclear counterstain: DAPI or Hoechst

  • Confocal imaging: For subcellular localization analysis

These protocols can be adapted based on specific experimental requirements and antibody characteristics.

What advanced methods can researchers use to quantify ligD expression and activity?

Advanced quantification of ligD expression and activity requires sophisticated methodological approaches:

Quantitative protein analysis:

  • Absolute quantification using purified standards and calibrated Western blotting

  • ELISA development with standard curves using recombinant ligD

  • Capillary Western systems (Wes, Jess) for enhanced reproducibility and sensitivity

  • Mass spectrometry with stable isotope-labeled peptide standards

Single-cell quantification approaches:

  • Flow cytometry with optimized permeabilization for intracellular ligD detection

  • Imaging flow cytometry for combined quantification and localization

  • Single-cell Western techniques for heterogeneity analysis

  • Proximity ligation assays for measuring protein interactions

Activity-based quantification:

  • In-gel activity assays for ligase functionality

  • Coupled enzyme assays monitoring ATP consumption

  • FRET-based biosensors for real-time activity tracking

  • High-throughput microplate assays for screening applications

Advanced imaging quantification:

  • Automated high-content imaging with machine learning analysis

  • Super-resolution microscopy for nanoscale distribution

  • FRAP (Fluorescence Recovery After Photobleaching) for mobility assessment

  • Live-cell imaging with fluorescently tagged ligD

When analyzing transgenic plants expressing bacterial ligD, researchers have successfully correlated protein levels detected by Western blotting with phenotypic changes in lignin structure measured by 2D NMR and UHPLC-MS .

Quantification MethodResolution LevelAdvantagesLimitations
Western blot densitometryPopulation averageSimple implementation, widely accessibleLimited dynamic range, semi-quantitative
Mass spectrometryAbsolute quantificationHigh accuracy, multiplexing capabilityComplex sample preparation, specialized equipment
ELISAPopulation averageHigh sensitivity, good for high-throughputRequires validated antibody pairs
Flow cytometrySingle-cell levelCaptures population heterogeneityLimited spatial information
Quantitative imagingSubcellular resolutionProvides spatial contextComplex image analysis, potential photobleaching

How can computational approaches enhance antibody-based ligD research?

Computational approaches significantly enhance antibody-based ligD research through multiple dimensions:

Epitope prediction and antibody design:

  • In silico analysis of ligD sequences to identify unique, accessible epitopes

  • Structural modeling to predict surface-exposed regions

  • Design of synthetic antibodies with enhanced specificity

  • Virtual screening of antibody libraries against ligD structural models

Image analysis automation:

  • Machine learning algorithms for automated Western blot quantification

  • Deep learning for cell segmentation in immunofluorescence images

  • Automated colocalization analysis in multi-channel microscopy

  • High-content screening data analysis for phenotypic profiling

Data integration frameworks:

  • Multi-omics approaches combining antibody data with genomics/proteomics

  • Network analysis of ligD interactions based on co-immunoprecipitation data

  • Systems biology modeling of ligD function in relevant pathways

  • Meta-analysis across multiple experimental datasets

Advanced structural applications:

  • Molecular dynamics simulations of antibody-ligD interactions

  • Computational prediction of conformational epitopes

  • Structure-based optimization of antibody binding properties

  • Integration of cryo-EM data with antibody epitope mapping

Advanced computational models can help identify distinct binding modes associated with different antibody specificities, as demonstrated in recent antibody engineering research . These models can predict how antibody sequence modifications affect binding to ligD, enabling rational design of improved research reagents.

For lignin-degrading ligD research, computational modeling of enzyme-substrate interactions can guide the selection of antibody epitopes that won't interfere with catalytic activity when used in functional studies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.